Digital NeuroPort Biopotential Signal Processing System

Digital NeuroPort Biopotential Signal Processing System is an FDA 510(k)-cleared medical device (K202174) manufactured by Blackrock Microsystems. This device is classified under the Neurology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on February 9, 2021. Regulation: 8.